Literature DB >> 10574143

Case report: acute encephalitis immediately prior to acute onset of hepatitis C virus infection.

H Fujita1, Y Chuganji, M Yaginuma, M Momoi, T Tanaka.   

Abstract

A 34-year-old male presented with acute viral encephalitis of unknown aetiology with subsequent acute onset of hepatitis C virus (HCV) infection. Although the neurological syndrome improved after administration of acyclovir, jaundice appeared. Neurological complications of HCV infections have rarely been described. In this case report, we discuss the close relationship between neurological syndromes and HCV infection. In the future, we hope that further discussion of clinical cases will determine whether or not the HCV produces neurological manifestations.

Entities:  

Mesh:

Year:  1999        PMID: 10574143     DOI: 10.1046/j.1440-1746.1999.02019.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  4 in total

1.  Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling.

Authors:  Amy D Paulino; Kiren Ubhi; Edward Rockenstein; Anthony Adame; Leslie Crews; Scott Letendre; Ronald Ellis; Ian P Everall; Igor Grant; Eliezer Masliah
Journal:  J Neurovirol       Date:  2011-06-10       Impact factor: 2.643

2.  Acute myelitis associated with HCV infection.

Authors:  Kentaro Suzuki; Masaki Takao; Yasuo Katayama; Ban Mihara
Journal:  BMJ Case Rep       Date:  2013-06-13

3.  Clinicopathologic correlates of hepatitis C virus in brain: a pilot study.

Authors:  Jacinta Murray; Sarah L Fishman; Elizabeth Ryan; Francis J Eng; José L Walewski; Andrea D Branch; Susan Morgello
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

4.  Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication.

Authors:  Marek Radkowski; Jeffrey Wilkinson; Marek Nowicki; Debra Adair; Hugo Vargas; Craig Ingui; Jorge Rakela; Tomasz Laskus
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.